Table 3.

Association of best corrected visual acuity (BCVA) with the classification and every parameter of the classification.

	Category	Median BCVA, logMAR (95% CI)	Median decimal BCVA	P-value
Classification	Simple	0.1 (0.05 to 0.18)	0.80	<0.0001
	Complex	0.2 (0.18 to 0.30)	0.64
Episode	Primary	0.18 (0.1 to 0.18)	0.66	0.23
	Resolved	0.48 (0.0 to 0.72)	0.33
	Recurrent	0.22 (0.17 to 0.30)	0.61	0.11a
Persistence	Non-persistent	0.17 (0.1 to 0.18)	0.66	0.0006
	Persistent	0.3 (0.18 to 0.48)	0.50
Presence of ORA	ORA absent	0.1 (0.05 to 0.16)	0.80	<0.0001
	ORA present	0.3 (0.19 to 0.45)	0.50
Presence of foveal involvement	No foveal involvement	0.0 (−0.08 to 0.34)	1.0	0.04
	Foveal involvement	0.18 (0.16 to 0.18)	0.66
Presence of MNV	MNV absent	0.18 (0.13 to 0.18)	0.66	0.12
	MNV present	0.26 (0.12 to 0.55)	0.55
Steroids use	No steroids use	0.18 (0.16 to 0.18)	0.66	0.34
	Steroids use	0.16 (0.0 to 0.18)	0.70

CI confidence interval, logMAR logarithm of the minimum angle of resolution, ORA outer retinal atrophy, MNV macular neovascularization.

^aprimary versus recurrent cases.